News
- Details
In June 2020, the Medsintez plant entered an agreement to join the Bioorganika Consortium of the Center for the National Technological Initiative of the Federal State Budgetary Institution 'Institute of Bioorganic Chemistry named after Academicians M. M. Shemyakin and Yu. A. Ovchinnikov' of the Russian Academy of Sciences (IBCh RAS).
- Details
On June 4, Alexey Orlov, First Deputy Governor of the Sverdlovsk Region, inspected a new medical mask workshop at the Medsintez plant, the largest pharmaceutical manufacturer in the Middle Urals.
- Details
On May 15, 2020, the Academic Board of the Ural State Medical University approved the instructional guidelines “On Using Triazavirin in Terms of Treatment and Post-Exposure Prophylaxis for the New Coronavirus Infection, COVID-19”.
- Details
- Details
Leading Russian scientists and clinicians included Triazavirin, the antiviral drug, in the interim “Drug treatment for acute respiratory viral infections (ARVI) in outpatient practices during the COVID-19 epidemic” guidelines. The guidelines on ARVI drug treatment have been posted on the website of the Ministry of Health of Russia and sent to Russian regions for reference of outpatient service doctors who deal with outpatients showing signs of ARVI.
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130